RBC Capital upgraded Bio-Techne (TECH) to Outperform from Sector Perform with a $73 price target
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TECH:
- CoreWeave upgraded, Instacart downgraded: Wall Street’s top analyst calls
- Bio-Techne upgraded to Buy from Neutral at Citi
- Strategic Divestiture and Focus on Core Strengths Justify Buy Rating for Bio-Techne
- Bio-Techne’s Strong Q4 Performance and Strategic Moves Justify Buy Rating
- Bio-Techne Reports Solid Q4 2025 Results Amid Strategic Shift